Erratum: Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors (Proceedings of the National Academy of Sciences of the United States of America (2016) 113 (4464-4469) DOI: 10.1073/pnas.1600007113);Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 16, 2016, Pages 4464-4469

  Krampitz, Geoffrey Wayne ^a,b   George, Benson M ^a,b   Willingham, Stephen B ^a,b   Volkmer, Jens Peter ^a,b   Weiskopf, Kipp ^a,b   Jahchan, Nadine ^a,c   Newman, Aaron M ^a,b   Sahoo, Debashis ^a,b,d   Zemek, Allison J ^a   Yanovsky, Rebecca L ^a,b   Nguyen, Julia K ^a,b   Schnorr, Peter J ^a,b   Mazur, Pawel K ^a   Sage, Julien ^a   Longacre, Teri A ^a   Visser, Brendan C ^a   Poultsides, George A ^a   Norton, Jeffrey A ^a,b   Weissman, Irving L ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c ORIC Pharmaceuticals   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cell; CD47; CD90; MET; Pancreatic neuroendocrine tumor

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE A1; CD47 ANTIGEN; CELL SURFACE PROTEIN; CETUXIMAB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD47; PANITUMUMAB; SCATTER FACTOR RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD47 PROTEIN, HUMAN; ISOENZYME; RETINAL DEHYDROGENASE; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CELL POPULATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPH NODE METASTASIS; MACROPHAGE; MOUSE; NONHUMAN; PANCREATIC NEUROENDOCRINE TUMOR; PHAGOCYTOSIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; UBIQUITINATION; ANIMAL; DRUG SCREENING; FEMALE; IMMUNOLOGY; MALE; METASTASIS; NEUROENDOCRINE TUMORS; NONOBESE DIABETIC MOUSE; PANCREATIC NEOPLASMS; PATHOLOGY; SCID MOUSE; TUMOR ESCAPE;

ANIMALS; ANTIGENS, CD47; ANTIGENS, THY-1; FEMALE; HUMANS; ISOENZYMES; MALE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RETINAL DEHYDROGENASE; TUMOR ESCAPE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84964394116     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1613319113     Document Type: Erratum

References (42)

1. Rindi G, Wiedenmann B (2012) Neuroendocrine neoplasms of the gut and pancreas: New insights. Nat Rev Endocrinol 8(1):54-64.
2. Yao JC, et al.; RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364(6):514-523.
3. Raymond E, et al. (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364(6):501-513.
4. Krampitz GW, Norton JA (2013) Pancreatic neuroendocrine tumors. Curr Probl Surg 50(11):509-545.
5. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111.
6. Lapidot T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464):645-648.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988.
8. Li C, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030-1037.
9. Yang ZF, et al. (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13(2):153-166.
10. Prehn RT (1972) The immune reaction as a stimulator of tumor growth. Science 176(4031):170-171.
11. Chao MP, Majeti R, Weissman IL (2012) Programmed cell removal: A new obstacle in the road to developing cancer. Nat Rev Cancer 12(1):58-67.
12. Willingham SB, et al. (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109(17):6662-6667.
13. Chao MP, et al. (2010) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142(5):699-713.
14. Weiskopf K, et al. (2013) Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341(6141):88-91.
15. Tseng D, et al. (2013) Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci USA 110(27): 11103-11108.
16. Sahoo D, Dill DL, Gentles AJ, Tibshirani R, Plevritis SK (2008) Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol 9(10):R157.
17. Peruzzi B, Bottaro DP (2006) Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12(12):3657-3660.
18. Zhang YW, et al. (2010) MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth. Cancer Res 70(17):6880-6890.
19. Sennino B, et al. (2012) Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2(3):270-287.
20. Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241(4861):58-62.
21. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L (2010) Molecular characterisation of side population cells with cancer stem cell-like characteristics in smallcell lung cancer. Br J Cancer 102(11):1636-1644.
22. Laird DJ, De Tomaso AW, Weissman IL (2005) Stem cells are units of natural selection in a colonial ascidian. Cell 123(7):1351-1360.
23. Gaur P, et al. (2011) Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology 141(5):1728-1737.
24. Hu Y, Smyth GK (2009) ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J ImmunolMethods 347(1-2):70-78.
25. Chao MP, et al. (2011) Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 71(4):1374-1384.
26. Jahchan NS, et al. (2013) A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov 3(12):1364-1377.
27. Quintana E, et al. (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18(5):510-523.
28. Boiko AD, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466(7302):133-137.
29. Schepers AG, et al. (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337(6095):730-735.
30. Christensen JG, Burrows J, Salgia R (2005) c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 225(1):1-26.
31. Jeffers M, Rong S, Vande Woude GF (1996) Hepatocyte growth factor/scatter factor- Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) 74(9): 505-513.
32. Rong S, et al. (1992) Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12(11):5152-5158.
33. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C (1993) Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange betweenmesenchyme and epithelia duringmouse development. J Cell Biol 123(1):223-235.
34. Jaiswal S, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138(2):271-285.
35. Trapnell C, et al. (2012) Differential gene and transcript expression analysis of RNAseq experiments with TopHat and Cufflinks. Nat Protoc 7(3):562-578.
36. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11(10):R106.
37. Trapnell C, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511-515.
38. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
39. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 25(14):1754-1760.
40. Li H, et al. (2009) The Sequence alignment/map (SAM) format and SAMtools. Bioinformatics 25(16):2078-2079.
41. Rosset A, Spadola L, Ratib O (2004) OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17(3):205-216.
42. Kim MP, et al. (2009) Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc 4(11):1670-1680.